Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.
COVID-19
Incubation period
Intrinsic generation time
Meta-analysis
Realized generation time
Serial interval
Systematic review
Variants of concern
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
29 09 2023
29 09 2023
Historique:
received:
17
05
2023
accepted:
05
09
2023
medline:
5
10
2023
pubmed:
30
9
2023
entrez:
29
9
2023
Statut:
epublish
Résumé
After the first COVID-19 wave caused by the ancestral lineage, the pandemic has been fueled from the continuous emergence of new SARS-CoV-2 variants. Understanding key time-to-event periods for each emerging variant of concern is critical as it can provide insights into the future trajectory of the virus and help inform outbreak preparedness and response planning. Here, we aim to examine how the incubation period, serial interval, and generation time have changed from the ancestral SARS-CoV-2 lineage to different variants of concern. We conducted a systematic review and meta-analysis that synthesized the estimates of incubation period, serial interval, and generation time (both realized and intrinsic) for the ancestral lineage, Alpha, Beta, and Omicron variants of SARS-CoV-2. Our study included 280 records obtained from 147 household studies, contact tracing studies, or studies where epidemiological links were known. With each emerging variant, we found a progressive shortening of each of the analyzed key time-to-event periods, although we did not find statistically significant differences between the Omicron subvariants. We found that Omicron BA.1 had the shortest pooled estimates for the incubation period (3.49 days, 95% CI: 3.13-4.86 days), Omicron BA.5 for the serial interval (2.37 days, 95% CI: 1.71-3.04 days), and Omicron BA.1 for the realized generation time (2.99 days, 95% CI: 2.48-3.49 days). Only one estimate for the intrinsic generation time was available for Omicron subvariants: 6.84 days (95% CrI: 5.72-8.60 days) for Omicron BA.1. The ancestral lineage had the highest pooled estimates for each investigated key time-to-event period. We also observed shorter pooled estimates for the serial interval compared to the incubation period across the virus lineages. When pooling the estimates across different virus lineages, we found considerable heterogeneities (I Our study supports the importance of conducting contact tracing and epidemiological investigations to monitor changes in SARS-CoV-2 transmission patterns. Our findings highlight a progressive shortening of the incubation period, serial interval, and generation time, which can lead to epidemics that spread faster, with larger peak incidence, and harder to control. We also consistently found a shorter serial interval than incubation period, suggesting that a key feature of SARS-CoV-2 is the potential for pre-symptomatic transmission. These observations are instrumental to plan for future COVID-19 waves.
Sections du résumé
BACKGROUND
After the first COVID-19 wave caused by the ancestral lineage, the pandemic has been fueled from the continuous emergence of new SARS-CoV-2 variants. Understanding key time-to-event periods for each emerging variant of concern is critical as it can provide insights into the future trajectory of the virus and help inform outbreak preparedness and response planning. Here, we aim to examine how the incubation period, serial interval, and generation time have changed from the ancestral SARS-CoV-2 lineage to different variants of concern.
METHODS
We conducted a systematic review and meta-analysis that synthesized the estimates of incubation period, serial interval, and generation time (both realized and intrinsic) for the ancestral lineage, Alpha, Beta, and Omicron variants of SARS-CoV-2.
RESULTS
Our study included 280 records obtained from 147 household studies, contact tracing studies, or studies where epidemiological links were known. With each emerging variant, we found a progressive shortening of each of the analyzed key time-to-event periods, although we did not find statistically significant differences between the Omicron subvariants. We found that Omicron BA.1 had the shortest pooled estimates for the incubation period (3.49 days, 95% CI: 3.13-4.86 days), Omicron BA.5 for the serial interval (2.37 days, 95% CI: 1.71-3.04 days), and Omicron BA.1 for the realized generation time (2.99 days, 95% CI: 2.48-3.49 days). Only one estimate for the intrinsic generation time was available for Omicron subvariants: 6.84 days (95% CrI: 5.72-8.60 days) for Omicron BA.1. The ancestral lineage had the highest pooled estimates for each investigated key time-to-event period. We also observed shorter pooled estimates for the serial interval compared to the incubation period across the virus lineages. When pooling the estimates across different virus lineages, we found considerable heterogeneities (I
CONCLUSIONS
Our study supports the importance of conducting contact tracing and epidemiological investigations to monitor changes in SARS-CoV-2 transmission patterns. Our findings highlight a progressive shortening of the incubation period, serial interval, and generation time, which can lead to epidemics that spread faster, with larger peak incidence, and harder to control. We also consistently found a shorter serial interval than incubation period, suggesting that a key feature of SARS-CoV-2 is the potential for pre-symptomatic transmission. These observations are instrumental to plan for future COVID-19 waves.
Identifiants
pubmed: 37775772
doi: 10.1186/s12916-023-03070-8
pii: 10.1186/s12916-023-03070-8
pmc: PMC10541713
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
374Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ . Accessed 20 April 2023.
Tracking SARS-CoV-2 variants. https://www.who.int/activities/tracking-SARS-CoV-2-variants/ . Accessed 20 April 2023.
Salvatore M, Purkayastha S, Ganapathi L, Bhattacharyya R, Kundu R, Zimmermann L, et al. Lessons from SARS-CoV-2 in India: a data-driven framework for pandemic resilience. Sci Adv. 2022;8(24):eabp8621.
Bolze A, Luo S, White S, Cirulli ET, Wyman D, Dei Rossi A, et al. SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads. Cell Rep Med. 2022;3(3):100564.
Aleem A, Akbar Samad AB, Vaqar S. Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). Treasure Island: StatPearls Publishing; 2023.
Zhang L, Li Q, Liang Z, Li T, Liu S, Cui Q, et al. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerg Microbes Infect. 2022;11(1):1–5.
pubmed: 34890524
Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci. 2007;274(1609):599–604.
pubmed: 17476782
He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–5.
pubmed: 32296168
Hu S, Wang W, Wang Y, Litvinova M, Luo K, Ren L, et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat Commun. 2021;12(1):1533.
pubmed: 33750783
pmcid: 7943579
Ali ST, Wang L, Lau EHY, Xu X-K, Du Z, Wu Y, et al. Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science. 2020;369(6507):1106–9.
pubmed: 32694200
pmcid: 7402628
Ali ST, Yeung A, Shan S, Wang L, Gao H, Du Z, et al. Serial Intervals and Case Isolation Delays for Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2022;74(4):685–94.
pubmed: 34037748
Zeng K, Santhya S, Soong A, Malhotra N, Pushparajah D, Thoon KC, et al. Serial intervals and incubation periods of SARS-CoV-2 Omicron and Delta variants, Singapore. Emerg Infect Dis. 2023;29(4):814.
Pung R, Mak TM, Kucharski AJ, Lee VJ. Serial intervals in SARS-CoV-2 B.1.617.2 variant cases. Lancet. 2021;398(10303):837–8.
pubmed: 34388398
pmcid: 8354568
Ahlers M, Aralis H, Tang W, Sussman JB, Fonarow GC, Ziaeian B. Non-pharmaceutical interventions and covid-19 burden in the United States: retrospective, observational cohort study. BMJ Med. 2022;1(1):e000030.
Hermesh T, Moltedo B, López CB, Moran TM. Buying time-the immune system determinants of the incubation period to respiratory viruses. Viruses. 2010;2(11):2541–58.
pubmed: 21994630
pmcid: 3185581
Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(8):e2228008.
Du Z, Liu C, Wang L, Bai Y, Lau EHY, Wu P, et al. Shorter serial intervals and incubation periods in SARS-CoV-2 variants than the SARS-CoV-2 ancestral strain. J Travel Med. 2022;29(6):taac052.
Madewell ZJ, Yang Y, Longini IM, Jr., Halloran ME, Vespignani A, Dean NE. Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants. BMC Infect Dis. 2023;23(1):429.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Champredon D, Dushoff J. Intrinsic and realized generation intervals in infectious-disease transmission. Proc Biol Sci. 2015;282(1821):20152026.
Manica M, Litvinova M, De Bellis A, Guzzetta G, Mancuso P, Vicentini M, et al. Estimation of the incubation period and generation time of SARS-CoV-2 Alpha and Delta variants from contact tracing data. Epidemiol Infect. 2023;151:e5.
Hart WS, Miller E, Andrews NJ, Waight P, Maini PK, Funk S, et al. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. Lancet Infect Dis. 2022;22(5):603–10.
McAloon C, Collins A, Hunt K, Barber A, Byrne AW, Butler F, et al. Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open. 2020;10(8):e039652.
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.
pubmed: 27683581
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.
pubmed: 31563865
pmcid: 10231495
Shen Y, Xu W, Li C, Handel A, Martinez L, Ling F, et al. A cluster of novel coronavirus disease 2019 infections indicating person-to-person transmission among casual contacts from social gatherings: an outbreak case-contact investigation. Open Forum Infect Dis. 2020;7(6):ofaa231–ofaa31.
Song JS, Lee J, Kim M, Jeong HS, Kim MS, Kim SG, et al. Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021. Emerg Infect Dis. 2022;28(3):756–9.
pubmed: 35107418
pmcid: 8888239
Manica M, De Bellis A, Guzzetta G, Mancuso P, Vicentini M, Venturelli F, et al. Intrinsic generation time of the SARS-CoV-2 Omicron variant: an observational study of household transmission. Lancet Reg Health Eur. 2022;19:100446.
Vazirinejad R, Khalili P, Jafarzadeh A, Shabani Z, Jamalizadeh A, Rezaei B, et al. A contact tracing prospective cohort retrieving epidemiological facts on SARS-CoV-2 transmission aspects; a serological analysis. Research Square. 2020.
Mefsin YM, Chen D, Bond HS, Lin Y, Cheung JK, Wong JY, et al. Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022. Emerg Infect Dis. 2022;28(9):1856–8.
Li L, Han ZG, Qin PZ, Liu WH, Yang Z, Chen ZQ, et al. Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: a population-based study. PLoS Negl Trop Dis. 2022;16(1):e0010048.
Bender JK, Brandl M, Höhle M, Buchholz U, Zeitlmann N. Analysis of asymptomatic and presymptomatic transmission in SARS-CoV-2 outbreak, Germany, 2020. Emerg Infect Dis. 2021;27(4):1159–63.
pubmed: 33600301
pmcid: 8007320
Ma X, Wu K, Li Y, Li S, Cao L, Xie H, et al. Contact tracing period and epidemiological characteristics of an outbreak of the SARS-CoV-2 Delta variant in Guangzhou. Int J Infect Dis. 2022;117:18–23.
pubmed: 35101637
pmcid: 8800156
Liu JY, Chen TJ, Hwang SJ. Analysis of community-acquired COVID-19 cases in Taiwan. J Chin Med Assoc. 2020;83(12):1087–92.
pubmed: 32796323
Del Águila-Mejía J, Wallmann R, Calvo-Montes J, Rodríguez-Lozano J, Valle-Madrazo T, Aginagalde-Llorente A. Secondary attack rate, transmission and incubation periods, and serial interval of SARS-CoV-2 Omicron variant, Spain. Emerg Infect Dis. 2022;28(6):1224.
pubmed: 35393009
pmcid: 9155885
Homma Y, Katsuta T, Oka H, Inoue K, Toyoshima C, Iwaki H, et al. The incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of other strains. J Infect. 2021;83(2):e15–7.
Haddad N, Clapham HE, Abou Naja H, Saleh M, Farah Z, Ghosn N, et al. Calculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data. BMC Infect Dis. 2021;21(1):1–6.
Shi P, Gao Y, Shen Y, Chen E, Chen H, Liu J, et al. Characteristics and evaluation of the effectiveness of monitoring and control measures for the first 69 Patients with COVID-19 from 18 January 2020 to 2 March in Wuxi, China. Sustain Cities Soc. 2021;64:102559.
Kang M, Xin H, Yuan J, Taslim Ali S, Liang Z, Zhang J, et al. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021. Euro Surveill. 2022;27(10):2100815.
Ogata T, Tanaka H, Irie F, Hirayama A, Takahashi Y. Shorter incubation period among unvaccinated Delta variant Coronavirus Disease 2019 patients in Japan. Int J Environ Res Public Health. 2022;19(3):1–15.
Zhang L, Zhu J, Wang X, Yang J, Liu XF, Xu X-K. Characterizing COVID-19 transmission: incubation period, reproduction rate, and multiple-generation spreading. Front Phys. 2021;8:589963.
Song R, Han B, Song M, Wang L, Conlon CP, Dong T, et al. Clinical and epidemiological features of COVID-19 family clusters in Beijing, China. J Infect. 2020;81(2):e26–30.
Brandal LT, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U, et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill. 2021;26(50):2101147.
Geismar C, Fragaszy E, Nguyen V, Fong WLE, Shrotri M, Beale S, et al. Serial interval of COVID-19 and the effect of Variant B.1.1.7: analyses from prospective community cohort study (Virus Watch). Wellcome Open Res. 2021;6:224–4.
Ryu S, Kim D, Lim JS, Ali ST, Cowling BJ. Serial interval and transmission dynamics during SARSCoV-2 Delta variant predominance, South Korea. Emerg Infect Dis. 2022;28(2):407–10.
Kremer C, Braeye T, Proesmans K, André E, Torneri A, Hens N. Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021. Emerg Infect Dis. 2022;28(8):1699–702.
pubmed: 35732195
pmcid: 9328897
Backer JA, Eggink D, Andeweg SP, Veldhuijzen IK, van Maarseveen N, Vermaas K, et al. Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021. Euro Surveill. 2022;27(6):2200042.
Kim D, Ali ST, Kim S, Jo J, Lim JS, Lee S, et al. Estimation of serial interval and reproduction number to quantify the transmissibility of SARS-CoV-2 Omicron variant in South Korea. Viruses. 2022;14(3):533.
pubmed: 35336939
pmcid: 8948735
Gupta M, Parameswaran GG, Sra MS, Mohanta R, Patel D, Gupta A, et al. Contact tracing of COVID-19 in Karnataka, India: Superspreading and determinants of infectiousness and symptomatic infection. PLoS ONE. 2022;17(7):e0270789.
Hwang H, Lim JS, Song SA, Achangwa C, Sim W, Kim G, et al. Transmission dynamics of the Delta variant of SARS-CoV-2 infections in South Korea. J Infect Dis. 2022;225(5):793–9.
Li D, Li AE, Li ZQ, Bao Y, Liu T, Qin XR, et al. SARS-CoV-2 Delta variant in Jingmen City, Hubei Province, China, 2021: children susceptible and vaccination breakthrough infection. Front Microbiol. 2022;13:856757.
Tanaka H, Ogata T, Shibata T, Nagai H, Takahashi Y, Kinoshita M, et al. Shorter incubation period among COVID-19 vases with the BA.1 Omicron variant. Int J Environ Res Public Health. 2022;19(10):1–7.
Bao C, Pan E, Ai J, Dai Q, Xu K, Shi N, et al. COVID-19 outbreak following a single patient exposure at an entertainment site: an epidemiological study. Transbound Emerg Dis. 2021;68(2):773–81.
Shim E, Choi W, Kwon D, Kim T, Song Y. Transmission potential of the Omicron variant of Severe Acute Respiratory Syndrome Coronavirus 2 in South Korea, 25 November 2021-8 January 2022. Open Forum Infect Dis. 2022;9(7):ofac248.
Amato L, Candeloro L, Di Girolamo A, Savini L, Puglia I, Marcacci M, et al. Epidemiological and genomic findings of the first documented Italian outbreak of SARS-CoV-2 Alpha variant of concern. Epidemics. 2022;39:100578.
Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers LA. Serial interval of COVID-19 among publicly reported confirmed cases. Emerg Infect Dis. 2020;26(6):1341–3.
Song Y, Shim E. Proportion of pre-symptomatic transmission events associated with COVID-19 in South Korea. J Clin Med. 2022;11(14):3925.
pubmed: 35887689
pmcid: 9324033
McAleavey P, Rainey E, McKaig C, Richardson C, Anderson C, Tilley C, et al. Outbreak of SARS-CoV-2 in a teenage discotheque in Northern Ireland-November 2021. Public Health. 2022;211:81–4.
pubmed: 36055066
Sang Woo Park KS. Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2. medRxiv. 2022.
Zhu W, Zhang M, Pan J, Yao Y, Wang W. Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study. BMC Med. 2021;19(1):1–11.
Allen H, Tessier E, Turner C, Anderson C, Blomquist P, Simons D, et al. Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England. medRxiv. 2022.
Helmsdal G, Hansen OK, Møller LF, Christiansen DH, Petersen MS, Kristiansen MF. Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple vaccinated healthcare workers. Clin Infect Dis. 2022;75(5):893–6.
pubmed: 35134167
Zhang M, Xiao J, Deng A, Zhang Y, Zhuang Y, Hu T, et al. Transmission dynamics of an outbreak of the COVID-19 Delta variant B.1.617.2 - Guangdong Province, China, May-June 2021. China CDC Wkly. 2021;3(27):584–6.
Ping K, Lei M, Gou Y, Tao Z, Yao G, Hu C, et al. Epidemiologic characteristics of covid-19 in guizhou province, China. J Infect Dev Ctries. 2021;15(3):389–97.
pubmed: 33839714
Liu Y, Zhao S, Ryu S, Ran J, Fan J, He D. Estimating the incubation period of SARS-CoV-2 Omicron BA.1 variant in comparison with that during the Delta variant dominance in South Korea. One Health. 2022;15:100425.
Deng B, Liu W, Guo Z, Luo L, Yang T, Huang J, et al. Natural history and cycle threshold values analysis of COVID-19 in Xiamen City, China. Infect Dis Model. 2022;7(3):486–97.
pubmed: 35968394
pmcid: 9361627
Ki M. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol Health. 2020;42:e2020007.
Buchholz U, An Der Heiden M. Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) are even shorter compared to Delta. Epidemiol Infect. 2022;150:e165.
pubmed: 35929470
The SARS-CoV-2 variant with lineage B.1.351 clusters investigation team. Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021. Euro Surveill. 2021;26(13):2100333.
Mao S, Huang T, Yuan H, Li M, Huang X, Yang C, et al. Epidemiological analysis of 67 local COVID-19 clusters in Sichuan Province, China. BMC Public Health. 2020;20(1):1525.
pubmed: 33032575
pmcid: 7543676
Ali ST, Chen D, Lim WW, Yeung A, Adam DC, Lau YC, et al. Insights into COVID-19 epidemiology and control from temporal changes in serial interval distributions in Hong Kong. medRxiv. 2022.
Yan X, Xiao W, Zhou S, Wang X, Wang Z, Zhao M, et al. A four-generation family transmission chain of COVID-19 along the China-Myanmar border in October to November 2021. Front Public Health. 2022;10:1004817.
pubmed: 36466467
pmcid: 9714430
Zhang X, Wang H, Wang Y, Lei Y, Xu K, Zhang J, et al. Epidemiological and clinical based study on four passages of COVID-19 patients: intervention at asymptomatic period contributes to early recovery. BMC Infect Dis. 2020;20(1):1–10.
Xiong W, Peng L, Tsang TK, Cowling BJ. Epidemiology of SARS-CoV-2 Omicron BA.5 Infections, Macau, June-July 2022. Emerg Infect Dis. 2023;29(2):453–6.
pubmed: 36648122
pmcid: 9881764
Wright E, Pollard G, Robertson H, Anuradha S. Household transmission of the Delta COVID-19 variant in Queensland, Australia: a case series. Epidemiol Infect. 2022;150:e173–e73.
Wei Z, Ma W, Wang Z, Li J, Fu X, Chang H, et al. Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: a case-ascertained study. Influenza Other Respi Viruses. 2023;17(2):e13097.
Yu X, Sun X, Cui P, Pan H, Lin S, Han R, et al. Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China. Transbound Emerg Dis. 2020;67(4):1697–707.
pubmed: 32351037
pmcid: 7267440
Wang K, Guo Z, Zeng T, Sun S, Lu Y, Wang J, et al. Transmission characteristics and inactivated vaccine effectiveness against transmission of SARS-CoV-2 Omicron BA.5 variants in Urumqi, China. JAMA Netw Open. 2023;6(3):e235755–e55.
Wang J, Ma T, Ding S, Xu K, Zhang M, Zhang Z, et al. Dynamic characteristics of a COVID-19 outbreak in Nanjing, Jiangsu province, China. Front Public Health. 2022;10:933075.
Ogata T, Tanaka H. SARS-CoV-2 incubation period during the Omicron BA.5- dominant period in Japan. Emerg Infect Dis. 2023;29(3):595–8.
Luo K, Wu Y, Wang Y, Liu Z, Yi L, Zhao S, et al. Transmission dynamics and epidemiological characteristics of the SARS-CoV-2 Delta variant - Hunan Province, China, 2021. China CDC Wkly. 2023;5(3):56–62.
Guo Z, Zhao S, Yam CHK, Li C, Jiang X, Chow TY, et al. Estimating the serial intervals of SARS-CoV-2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong. Influenza Other Respi Viruses. 2023;17(2):e13105.
Guo Z, Zhao S, Mok CKP, So RTY, Yam CHK, Chow TY, et al. Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants. J Med Virol. 2023;95(3):e28648.
Geismar C, Nguyen V, Fragaszy E, Shrotri M, Navaratnam AMD, Beale S, et al. Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch). Lancet. 2022;400:S40.
pubmed: 36929985
pmcid: 9691060
Guo CX, He L, Yin JY, Meng XG, Tan W, Yang GP, et al. Epidemiological and clinical features of pediatric COVID-19. BMC Med. 2020;18(1):1–7.
Nie X, Fan L, Mu G, Tan Q, Wang M, Xie Y, et al. Epidemiological characteristics and incubation period of 7015 confirmed cases with Coronavirus Disease 2019 outside Hubei Province in China. J Infect Dis. 2020;222(1):26–35.
pubmed: 32339231
Yu S, Cui S, Rui J, Zhao Z, Deng B, Liu C, et al. Epidemiological characteristics and transmissibility for SARS-CoV-2 of population level and cluster level in a Chinese City. Front Public Health. 2021;9:799536.
Wang P, Lu JA, Jin Y, Zhu M, Wang L, Chen S. Statistical and network analysis of 1212 COVID-19 patients in Henan, China. Int J Infect Dis. 2020;95:391–8.
pubmed: 32339715
pmcid: 7180361
Son H, Lee H, Lee M, Eun Y, Park K, Kim S, et al. Epidemiological characteristics of and containment measures for COVID-19 in Busan, Korea. Epidemiol Health. 2020;42:e2020035.
Baskaradoss JK, Alsumait A, Malik S, Ariga J, Geevarghese A, Francis R, et al. Epidemiological characteristics of COVID-19 cases among indians residing in Kuwait. East Mediterr Health J. 2021;27(8):745–54.
pubmed: 34486710
Bae S, Kim H, Jung TY, Lim JA, Jo DH, Kang GS, et al. Epidemiological characteristics of COVID-19 outbreak at fitness centers in Cheonan, Korea. J Korean Med Sci. 2020;35(31):e288.
Du S, Lu H, Su Y, Wang X, Bi S, Wu J, et al. Epidemiological characteristics of COVID-19 under government-mandated control measures during January-February 2020 in Inner Mongolia, China. Jpn J Infect Dis. 2021;75(4):361–7.
pubmed: 34980704
Thway AM, Teza H, Win TT, Htun YM, Aung MM, Win YN, et al. Epidemiological characteristics of SARS-COV-2 in Myanmar. medRxiv. 2020.
Kwok KO, Wong VWY, Wei WI, Wong SYS, Tang JWT. Epidemiological characteristics of the first 53 laboratory-confirmed cases of COVID-19 epidemic in Hong Kong, 13 February 2020. Euro Surveill. 2020;25(16):2000155.
Lai CKC, Ng RWY, Wong MCS, Chong KC, Yeoh YK, Chen Z, et al. Epidemiological characteristics of the first 100 cases of coronavirus disease 2019 (COVID-19) in Hong Kong Special Administrative Region, China, a city with a stringent containment policy. Int J Epidemiol. 2020;49(4):1096–105.
pubmed: 32601677
Jia J, Hu X, Yang F, Song X, Dong L, Zhang J, et al. Epidemiological characteristics on the clustering nature of COVID-19 in Qingdao City, 2020: a descriptive analysis. Disaster Med Public Health Prep. 2020;14(5):643–7.
Hua CZ, Miao ZP, Zheng JS, Huang Q, Sun QF, Lu HP, et al. Epidemiological features and viral shedding in children with SARS-CoV-2 infection. J Med Virol. 2020;92(11):2804–12.
pubmed: 32542750
pmcid: 7323101
Wong J, Chaw L, Koh WC, Alikhan MF, Jamaludin SA, Poh WWP, et al. Epidemiological investigation of the first 135 COVID-19 cases in Brunei: implications for surveillance, control, and travel restrictions. Am J Trop Med Hyg. 2020;103(4):1608–13.
Haw NJL, Uy J, Sy KTL, Abrigo MRM. Epidemiological profile and transmission dynamics of COVID-19 in the Philippines. Epidemiol Infect. 2020;148:e204.
Zhang Q, Zhu J, Jia C, Xu S, Jiang T, Wang S. Epidemiology and clinical outcomes of COVID-19 patients in Northwestern China who had a history of exposure in Wuhan City: departure time-originated pinpoint surveillance. Front Med (Lausanne). 2021;8:582299.
Ganyani T, Kremer C, Chen D, Torneri A, Faes C, Wallinga J, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill. 2020;25(17):2000257.
Hart WS, Abbott S, Endo A, Hellewell J, Miller E, Andrews N, et al. Inference of the SARS-CoV-2 generation time using UK household data. Elife. 2022;11:e70767.
Zhao S, Tang B, Musa SS, Ma S, Zhang J, Zeng M, et al. Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data. Epidemics. 2021;36:100482.
Lau YC, Tsang TK, Kennedy-Shaffer L, Kahn R, Lau EHY, Chen D, et al. Joint estimation of generation time and incubation period for Coronavirus Disease (Covid-19). J Infect Dis. 2021;224(10):1664–71.
Deng Y, You C, Liu Y, Qin J, Zhou XH. Estimation of incubation period and generation time based on observed length-biased epidemic cohort with censoring for COVID-19 outbreak in China. Biometrics. 2021;77(3):929–41.
pubmed: 32627172
Böhm S, Woudenberg T, Chen D, Marosevic DV, Böhmer MM, Hansen L, et al. Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany. Epidemiol Infect. 2021;149:e65.
Böhmer MM, Buchholz U, Corman VM, Hoch M, Katz K, Marosevic DV, et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. Lancet Infect Dis. 2020;20(8):920–8.
pubmed: 32422201
pmcid: 7228725
Wu J, Huang Y, Tu C, Bi C, Chen Z, Luo L, et al. Household transmission of SARS-CoV-2, Zhuhai, China, 2020. Clin Infect Dis. 2020;71(16):2099–108.
Yang L, Dai J, Zhao J, Wang Y, Deng P, Wang J. Estimation of incubation period and serial interval of COVID-19: analysis of 178 cases and 131 transmission chains in Hubei province, China. Epidemiol Infect. 2020;148:e117.
Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020;20(7):793–802.
pubmed: 32247326
pmcid: 7269887
Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20 28 January 2020. Euro Surveill. 2020;25(5):2000062.
Bui LV, Nguyen HT, Levine H, Nguyen HN, Nguyen TA, Nguyen TP, et al. Estimation of the incubation period of COVID-19 in Vietnam. PLoS ONE. 2020;15(12):e0243889.
Cheng C, Zhang D, Dang D, Geng J, Zhu P, Yuan M, et al. Incubation period of COVID-19 from 11545 patients in observation study. Research Square. 2021.
Han T. Outbreak investigation: transmission of COVID-19 started from a spa facility in a local community in Korea. Epidemiol Health. 2020;42:e2020056.
Kong TK. Longer incubation period of Coronavirus Disease 2019 (COVID-19) in older adults. Aging Med (Milton). 2020;3(2):102–9.
pubmed: 32661509
Men K, Wang X, Yihao L, Zhang G, Hu J, Gao Y, et al. Estimate the incubation period of coronavirus 2019 (COVID-19). medRxiv. 2020.
Xiao Z, Guo W, Luo Z, Liao J, Wen F, Lin Y. Examining geographical disparities in the incubation period of the COVID-19 infected cases in Shenzhen and Hefei, China. Environ Health Prev Med. 2021;26(1):1–10.
Xiao Z, Xie X, Guo W, Luo Z, Liao J, Wen F, et al. Examining the incubation period distributions of COVID-19 on Chinese patients with different travel histories. J Infect Dev Ctries. 2020;14(4):323–7.
pubmed: 32379707
Ratovoson R, Razafimahatratra R, Randriamanantsoa L, Raberahona M, Rabarison HJ, Rahaingovahoaka FN, et al. Household transmission of COVID-19 among the earliest cases in Antananarivo, Madagascar. Influenza Other Respi Viruses. 2022;16(1):48–55.
Aghaali M, Kolifarhood G, Nikbakht R, Saadati HM, Hashemi Nazari SS. Estimation of the serial interval and basic reproduction number of COVID-19 in Qom, Iran, and three other countries: a data-driven analysis in the early phase of the outbreak. Transbound Emerg Dis. 2020;67(6):2860–8.
Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911–9.
pubmed: 32353347
pmcid: 7185944
Chu VT, Yousaf AR, Chang K, Schwartz NG, McDaniel CJ, Lee SH, et al. Household Transmission of SARS-CoV-2 from Children and Adolescents. N Engl J Med. 2021;385(10):954–6.
pubmed: 34289272
Expert Taskforce for the C-CSO. Epidemiology of COVID-19 outbreak on cruise ship quarantined at Yokohama, Japan, February 2020. Emerg Infect Dis. 2020;26(11):2591–7.
McAloon CG, Wall P, Griffin J, Casey M, Barber A, Codd M, et al. Estimation of the serial interval and proportion of pre-symptomatic transmission events of COVID- 19 in Ireland using contact tracing data. BMC Public Health. 2021;21(1):805.
pubmed: 33906635
pmcid: 8076671
Ng SH-X, Kaur P, Kremer C, Tan WS, Tan AL, Hens N, et al. Estimating transmission parameters for COVID-19 clusters by using symptom onset data, Singapore, January-April 2020. Emerg Infect Dis. 2021;27(2):582–5.
Talmoudi K, Safer M, Letaief H, Hchaichi A, Harizi C, Dhaouadi S, et al. Estimating transmission dynamics and serial interval of the first wave of COVID-19 infections under different control measures: a statistical analysis in Tunisia from February 29 to May 5, 2020. BMC Infect Dis. 2020;20(1):914.
pubmed: 33267823
pmcid: 7708891
Wang K, Zhao S, Liao Y, Zhao T, Wang X, Zhang X, et al. Estimating the serial interval of the novel coronavirus disease (COVID-19) based on the public surveillance data in Shenzhen, China, from 19 January to 22 February 2020. Transbound Emerg Dis. 2020;67(6):2818–22.
pubmed: 32452648
pmcid: 7283843
Kwok KO, Wei WI, Huang Y, Kam KM, Chan EYY, Riley S, et al. Evolving epidemiological characteristics of COVID-19 in Hong Kong from January to August 2020: retrospective study. J Med Internet Res. 2021;23(4):e26645.
Chong DWQ, Jayaraj VJ, Ng CW, Sam IC, Said MA, Ahmad Zaki R, et al. Propagation of a hospitalassociated cluster of COVID-19 in Malaysia. BMC Infect Dis. 2021;21(1):1–12.
Dai J, Yang L, Zhao J. Probable longer incubation period for elderly Covid-19 cases: analysis of 180 contact tracing data in Hubei province, China. Risk Manag Healthc Policy. 2020;13:1111–7.
pubmed: 32848488
pmcid: 7429221
Huang L, Zhang X, Zhang X, Wei Z, Zhang L, Xu J, et al. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study. J Infect. 2020;80(6):e1–3.
Li M, Chen P, Yuan Q, Song B, Ma J. Transmission characteristics of the COVID-19 outbreak in China: a study driven by data. medRxiv. 2020.
Areekal B, Vijayan SM, Suseela MS, Andrews MA, Ravi RK, Sukumaran ST, et al. Risk factors, epidemiological and clinical outcome of close contacts of Covid-19 cases in a tertiary hospital in Southern India. J Clin Diagnostic Res. 2021;15(3):LC34–7.
Cao Y, Wang Y, Das A, Pan CQ, Xie W. Transmission dynamics of COVID-19 among index case family clusters in Beijing, China. Epidemiol Infect. 2020;149:e74.
Chun JY, Baek G, Kim Y. Transmission onset distribution of COVID-19. Int J Infect Dis. 2020;99:403–7.
pubmed: 32771633
pmcid: 7409940
Tindale LC, Stockdale JE, Coombe M, Garlock ES, Lau WYV, Saraswat M, et al. Evidence for transmission of COVID-19 prior to symptom onset. Elife. 2020;9:e57149.
Won YS, Kim JH, Ahn CY, Lee H. Subcritical transmission in the early stage of Covid-19 in Korea. Int J Environ Res Public Health. 2021;18(3):1–10.
Xia W, Liao J, Li C, Li Y, Qian X, Sun X, et al. Transmission of Corona Virus Disease 2019 during the incubation period may lead to a quarantine loophole. medRxiv. 2020.
Zhao H, Zhang Z, Lun W, Chen Z, Lu X, Li J, et al. Transmission dynamics and successful control measures of SARS-CoV-2 in the mega-size city of Guangzhou, China. Medicine (Baltimore). 2021;100(48):e27846.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of Coronavirus Disease 2019 (CoVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82.
Emecen AN, Basoglu Sensoy E, Sezgin E, Yildirim Ustuner B, Keskin S, Siyve N, et al. Transmission dynamics and timing of key events for SARS-CoV-2 infection in healthcare workers. Infect Dis (Lond). 2021;53(7):531–7.
pubmed: 33729905
Li M, Liu K, Song Y, Wang M, Wu J. Serial interval and generation interval for imported and local infectors, respectively, estimated using reported contact-tracing data of COVID-19 in China. Front Public Health. 2020;8:577431.
Bernal Lopez J, Panagiotopoulos N, Byers C, Vilaplana TG, Boddington N, Zhang XS, et al. Transmission dynamics of COVID-19 in household and community settings in the United Kingdom, January to March 2020. Euro Surveill. 2022;27(15):2001551.
Cereda D, Manica M, Tirani M, Rovida F, Demicheli V, Ajelli M, et al. The early phase of the COVID-19 epidemic in Lombardy, Italy. Epidemics. 2021;37:100528.
Hong K, Yum S, Kim J, Chun BC. The serial interval of COVID-19 in Korea: 1,567 pairs of symptomatic cases from contact tracing. J Korean Med Sci. 2020;35(50):e435.
Lavezzo E, Franchin E, Ciavarella C, Cuomo-Dannenburg G, Barzon L, Del Vecchio C, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 2020;584(7821):425–9.
Liu T, Qi L, Yao M, Tian K, Lin M, Jiang H, et al. Serial interval and reproductive number of COVID-19 among 116 infector-infectee pairs - Jingzhou City, Hubei province, China, 2020. China CDC Wkly. 2020;2(27):491–5.
Najafi F, Izadi N, Hashemi-Nazari SS, Khosravi-Shadmani F, Nikbakht R, Shakiba E. Serial interval and time-varying reproduction number estimation for COVID-19 in western Iran. New Microbes New Infect. 2020;36:100715.
Prete CA, Buss L, Dighe A, Porto VB, da Silva Candido D, Ghilardi F, et al. Serial interval distribution of SARS-CoV-2 infection in Brazil. J Travel Med. 2021;28(2):taaa115.
Reed IG, Walker ES, Landguth EL. SARS-CoV-2 Serial Interval Variation, Montana, USA, March 1-July 31, 2020. Emerg Infect Dis. 2021;27(5):1486–91.
Ryu S, Ali ST, Noh E, Kim D, Lau EHY, Cowling BJ. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea. BMC Infect Dis. 2021;21(1):1–9.
Saurabh S, Verma MK, Gautam V, Kumar N, Goel AD, Gupta MK, et al. Transmission dynamics of the COVID-19 epidemic at the district level in India: prospective observational study. JMIR Public Health Surveill. 2020;6(4):e22678.
Thai PQ, Rabaa MA, Luong DH, Tan DQ, Quang TD, Quach HL, et al. The first 100 days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) control in Vietnam. Clin Infect Dis. 2021;72(9):E334–E42.
Wang Y, Siesel C, Chen Y, Lopman B, Edison L, Thomas M, et al. Severe Acute Respiratory Syndrome Coronavirus 2 transmission in Georgia, USA, February 1-July 13, 2020. Emerg Infect Dis. 2021;27(10):2578–87.
Qin J, You C, Lin Q, Hu T, Yu S, Zhou XH. Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study. Sci Adv. 2020;6(33):eabc1202.
Ren X, Li Y, Yang X, Li Z, Cui J, Zhu A, et al. Evidence for pre-symptomatic transmission of Coronavirus Disease 2019 (COVID-19) in China. Influenza Other Respi Viruses. 2021;15(1):19–26.
Zhao S, Gao D, Zhuang Z, Chong MKC, Cai Y, Ran J, et al. Estimating the serial interval of the Novel Coronavirus Disease (COVID-19): a statistical analysis using the public data in Hong Kong from January 16 to February 15, 2020. Front Phys. 2020;8:347.
Adam DC, Wu P, Wong JY, Lau EHY, Tsang TK, Cauchemez S, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020;26(11):1714–9.
pubmed: 32943787
Ferretti L, Wymant C, Kendall M, Zhao L, Nurtay A, Abeler-Dorner L, et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. 2020;368(6491):eabb6936.
Althobaity Y, Wu J, Tildesley MJ. A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia. Infect Dis Model. 2022;7(3):473–85.
pubmed: 35938094
pmcid: 9343745
Wang Y, Sun K, Pan Y, Yi L, Huo D, Wu Y, et al. SARS-CoV-2 containment was achievable during the early stage of the pandemic: a retrospective modelling study of the Xinfadi outbreak in Beijing. medRxiv. 2022.
Achangwa C, Park H, Ryu S. Incubation period of wild type of SARS-CoV-2 infections by age, gender, and epidemic periods. Front Public Health. 2022;10:905020.
Zhao Q, Zhang Y, Li M, Tian R, Zhao Y, Cao B, et al. Epidemiological clustered characteristics of Coronavirus Disease 2019 (COVID-19) in three phases of transmission in Jilin Province, China. PLoS ONE. 2023;18(1):e0279879.
Somda SMA, Ouedraogo B, Pare CB, Kouanda S. Estimation of the serial interval and the effective reproductive number of COVID-19 outbreak using contact data in Burkina Faso, a Sub-Saharan African country. Comput Math Methods Med. 2022;2022:8239915.
Hammond V, Butchard M, Stablein H, Jack S. COVID-19 in one region of New Zealand: a descriptive epidemiological study. Aust N Z J Public Health. 2022;46(6):745–50.
pubmed: 36190206
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207.
pubmed: 31995857
pmcid: 7121484
Ma S, Zhang J, Zeng M, Yun Q, Guo W, Zheng Y, et al. Epidemiological parameters of Coronavirus Disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries. medRxiv. 2020.
Rathore V, Galhotra A, Pal R, Sahu KK. COVID-19 pandemic and children: a review. J Pediatr Pharmacol Ther. 2020;25(7):574–85.
pubmed: 33041712
pmcid: 7541032
Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J. 2020;39(6):469–77.
pubmed: 32398569
pmcid: 7363381
Daley C, Fydenkevez M, Ackerman-Morris S. A systematic review of the incubation period of SARS-CoV-2: the effects of age, biological sex, and location on incubation period. medRxiv. 2020.
Li Z, Zhang Y, Wang C, Peng L, Gao R, Jing J, et al. The incubation period of Severe Acute Respiratory Syndrome Coronavirus 2: a systematic review. medRxiv. 2020.
Wang Y, Cao Z, Zeng DD, Zhang Q, Luo T. The collective wisdom in the COVID-19 research: comparison and synthesis of epidemiological parameter estimates in preprints and peer reviewed articles. Int J Infect Dis. 2021;104:1–6.
pubmed: 33352327
Wei Y, Wei L, Liu Y, Huang L, Shen S, Zhang R, et al. Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis. Infection. 2021;50(4):803–13.
pubmed: 34409563
pmcid: 8372687
Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W. Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):1–12.
Zaki N, Mohamed EA. The estimations of the COVID-19 incubation period: a scoping reviews of the literature. J Infect Public Health. 2021;14(5):638–46.
pubmed: 33848893
pmcid: 7869687
Song WL, Zou N, Guan WH, Pan JL, Xu W. Clinical characteristics of COVID-19 in family clusters: a systematic review. World J Pediatr. 2021;17(4):355–63.
pubmed: 34170503
pmcid: 8229253
Griffin J, Casey M, Collins Á, Hunt K, McEvoy D, Byrne A, et al. Rapid review of available evidence on the serial interval and generation time of COVID-19. BMJ Open. 2020;10(11):e040263.
Allen K, Parry AE, Glass K. Early reports of epidemiological parameters of the COVID-19 pandemic. Western Pac Surveill Response J. 2021;12(2):65–81.
pubmed: 34540315
pmcid: 8421745
Biggerstaff M, Cowling BJ, Cucunubá ZM, Dinh L, Ferguson NM, Gao H, et al. Early insights from statistical and mathematical modeling of key epidemiologic parameters of COVID-19. Emerg Infect Dis. 2020;26(11):E1–E14.
Alene M, Yismaw L, Assemie MA, Ketema DB, Gietaneh W, Birhan TY. Serial interval and incubation period of COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):257.
pubmed: 33706702
pmcid: 7948654
Cheng C, Zhang DD, Dang D, Geng J, Zhu P, Yuan M, et al. The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients. Infect Dis Poverty. 2021;10(1):1–13.
Dhouib W, Maatoug J, Ayouni I, Zammit N, Ghammem R, Fredj SB, et al. The incubation period during the pandemic of COVID-19: a systematic review and meta-analysis. Syst Rev. 2021;10(1):1–14.
Elias C, Sekri A, Leblanc P, Cucherat M, Vanhems P. The incubation period of COVID-19: a meta-analysis. Int J Infect Dis. 2021;104:708–10.
Izadi N, Taherpour N, Mokhayeri Y, Sotoodeh Ghorbani S, Rahmani K, Hashemi Nazari SS. Epidemiologic parameters for COVID-19: a systematic review and meta-analysis. Med J Islam Repub Iran. 2022;36:155.
Khalili M, Karamouzian M, Nasiri N, Javadi S, Mirzazadeh A, Sharifi H. Epidemiological characteristics of COVID-19; a systemic review and meta-analysis. medRxiv. 2020.
Li B, Zhang S, Zhang R, Chen X, Wang Y, Zhu C. Epidemiological and clinical characteristics of COVID-19 in children: a systematic review and meta-analysis. Front Pediatr. 2020;8:591132.
Quesada JA, López-Pineda A, Gil-Guillén VF, Arriero-Marín JM, Gutiérrez F, Carratala-Munuera C. Incubation period of COVID-19: a systematic review and meta-analysis. Rev Clin Esp. 2021;221(2):109–17.
Rai B, Shukla A, Dwivedi LK. Incubation period for COVID-19: a systematic review and meta-analysis. J Public Health. 2021:1–8.
Rai B, Shukla A, Dwivedi LK. Estimates of serial interval for COVID-19: a systematic review and meta-analysis. Clin Epidemiol Glob Health. 2021;9:157–61.
Rampal S, Jayaraj VJ, Chong DWQ, Ng C-W. A meta-analysis of the serial interval and generation time of COVID-19 transmission. Int J Epidemiol. 2021;50.
Wassie GT, Azene AG, Bantie GM, Dessie G, Aragaw AM. Incubation period of severe acute respiratory syndrome novel Coronavirus 2 that causes Coronavirus disease 2019: a systematic review and meta-analysis. Curr Ther Res Clin Exp. 2020;93:100607.
Wei Y, Wei L, Liu Y, Huang L, Shen S, Zhang R, et al. A systematic review and meta-analysis reveals long and dispersive incubation period of COVID-19. medRxiv. 2020.
Xin H, Wong JY, Murphy C, Yeung A, Taslim Ali S, Wu P, et al. The incubation period distribution of Coronavirus disease 2019: a systematic review and meta-analysis. Clin Infect Dis. 2021;73(12):2344–52.
Zhang T, Ding S, Zeng Z, Cheng H, Zhang C, Mao X, et al. Estimation of incubation period and serial interval for SARS-CoV-2 in Jiangxi, China, and an Updated Meta-Analysis. J Infect Dev Ctries. 2021;15(3):326–32.
Yang Y, Kenah E. Understanding how fast SARS-CoV-2 variants transmit from household studies. Lancet Infect Dis. 2022;22(5):564–5.
Lee M, Fayad M, Mabud T, De Lara PT, Hernandez AE, Contreras Anez GA, et al. Clinical characteristics of early noncritical hospitalized patients with coronavirus disease 2019 (COVID-19): a single-center retrospective study in New York City. Open Forum Infect Dis. 2020;7(SUPPL 1):S287–S88.
Mersini K, Vasili A, Dervishi M, Kureta E, Robo A, Alla L, et al. Early phase of COVID-19 epidemic in Albania. Int J Infect Dis. 2022;116:S26–7.
Sukhyun R, Achangwa C. No difference in the incubation period of COVID-19 in different gender, ages, and epidemic periods in South Korea. Int J Infect Dis. 2022;116:S53.
Werajong O, Denduangchai S, Deepreecha K, Bhopdhornangkul B. The characteristic of the COVID-19 outbreak in The Royal Thai Army personal during 1st April to 8th May 2021 and Preventive Policy suggestion. Saf Health Work. 2022;13:S175.
Wu J, Chen X, Gong L, Huo S, Gao X, Nie S, et al. Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China. Int J Infect Dis. 2022;117:372–7.
Wang Y, Wang Q, Wang K, Song C, Guo Z, Hu W. A case of COVID-19 with an ultralong incubation period. Infect Control Hosp Epidemiol. 2021;42(2):242–3.
Soedarsono S. A family cluster of Coronavirus disease (COVID-19) infection with different clinical manifestations. Acta Med Indones. 2020;52(2):155–62.
Du X, Kang K, Chong Y, Zhang ML, Yang W, Meng XL, et al. COVID-19 patient with an incubation period of 27 d: a case report. World J Clin Cases. 2021;9(21):5955–62.
Koff AG, Laurent-Rolle M, Hsu JCC, Malinis M. Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy. Infect Control Hosp Epidemiol. 2021;42(10):1286–8.
Zheng Y, Xiong C, Liu Y, Qian X, Tang Y, Liu L, et al. Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020. Pharmacol Res. 2020;157:104821.
Ito K, Piantham C, Nishiura H. Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark. Math Biosci Eng. 2022;19(9):9005–17.
Capon A, Ousta D, Ferson M, Ingleton A, Sheppeard V. A multiple site community outbreak of COVID-19 in Sydney, Australia. Aust N Z J Public Health. 2021;45(2):129–32.
Pantoja-Melendez C, Garcia-De la Torre G, Duran-Robertson M, Peterson-Marquard K, Nunez-Amador S, Gomez-Bocanegra V, et al. COVID-19 Outbreak during summer courses at an elementary school. Children (Basel). 2023;10(3):418.
Chen D, Lau YC, Xu XK, Wang L, Du Z, Tsang TK, et al. Inferring time-varying generation time, serial interval, and incubation period distributions for COVID-19. Nat Commun. 2022;13(1):7727.
Rajendrakumar AL, Nair ATN, Nangia C, Chourasia PK, Chourasia MK, Syed MG, et al. Epidemic landscape and forecasting of SARS-CoV-2 in India. J Epidemiol Glob Health. 2021;11(1):55–9.
Ma S, Zhang J, Zeng M, Yun Q, Guo W, Zheng Y, et al. Epidemiological parameters of COVID-19: case series study. J Med Internet Res. 2020;22(10):e19994.
Huang S, Li J, Dai C, Tie Z, Xu J, Xiong X, et al. Incubation period of coronavirus disease 2019: new implications for intervention and control. Int J Environ Health Res. 2022;32(8):1707–15.
Lee H, Kim K, Choi K, Hong S, Son H, Ryu S. Incubation period of the Coronavirus Disease 2019 (COVID-19) in Busan, South Korea. J Infect Chemother. 2020;26(9):1011–13.
Tomie T. Incubation period of COVID-19 in the “live-house” cluster of accurately known infection events and delay time from symptom onset of public reporting observed in cases in Osaka, Japan. medRxiv. 2020.
Singh G, Patrikar S, Sankara Sarma P, Soman B. Time-dependent dynamic transmission potential and instantaneous reproduction number of COVID-19 pandemic in India. medRxiv. 2020.
Nishiura H, Linton NM, Akhmetzhanov AR. Serial interval of Novel Coronavirus (COVID-19) infections. Int J Infect Dis. 2020;93:284–6.
pubmed: 32145466
pmcid: 7128842
Knight J, Mishra S. Estimating effective reproduction number using generation time versus serial interval, with application to COVID-19 in the Greater Toronto Area, Canada. Infect Dis Model. 2020;5:889–96.
pubmed: 33163739
pmcid: 7604055
Cai W, Yang Z, Liang J, Lin Z, Ma Y, Chen C, et al. How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share. Front Public Health. 2022;10:979063.
Wang Y, Chen R, Hu F, Lan Y, Yang Z, Zhan C, et al. Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China. EClinicalMedicine. 2021;40:101129.
Abbott S, Sherratt K, Gerstung M, Funk S. Estimation of the test to test distribution as a proxy for generation interval distribution for the Omicron variant in England. medRxiv. 2022.
Hao J, Hu XC, Fan MX, Chen J, Cheng QR, Li Z, et al. Analysis of clinical characteristics of 66 pediatric patients with B.1.617.2 (Delta) variant of COVID-19. World J Pediatr. 2022;18(5):343–49.
Grant R, Charmet T, Schaeffer L, Galmiche S, Madec Y, Von Platen C, et al. Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: results from a nationwide case-control study in France. Lancet Reg Health Eur. 2022;13:100278.
Weil AA, Luiten KG, Casto AM, Bennett JC, O’Hanlon J, Han PD, et al. Mapping the emergence of SARS-CoV-2 Omicron variants on a university campus. medRxiv. 2022.
Cortés Martínez J, Pak D, Abelenda-Alonso G, Langohr K, Ning J, Rombauts A, et al. SARS-Cov-2 incubation period according to vaccination status during the fifth COVID-19 wave in a tertiary-care center in Spain: a cohort study. BMC Infect Dis. 2022;22(1):1–7.
Han YN, Feng ZW, Sun LN, Ren XX, Wang H, Xue YM, et al. A comparative-descriptive analysis of clinical characteristics in 2019-coronavirus-infected children and adults. J Med Virol. 2020;92(9):1596–602.
Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;80(4):401–6.
Shiel E, Miyakis S, Tennant E, Fernando S, Kizny-Gordon A, Koh B, et al. Clinical characteristics and outcomes of COVID-19 in a low-prevalence, well resourced setting, Sydney, Australia. Intern Med J. 2021;51(10):1605–13.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health. 2020;13(7):920–25.
Wang Y, Liao B, Guo Y, Li F, Lei C, Zhang F, et al. Clinical characteristics of patients infected with the Novel 2019 Coronavirus (Sars-Cov-2) in Guangzhou, China. Open Forum Infect Dis. 2020;7(6):ofaa187.
Yang J, Wu K, Ding A, Li L, Lu H, Zhu W, et al. Clinical characteristics, treatment, and prognosis of 74 2019 Novel Coronavirus Disease patients in Hefei: a single-center retrospective study. Medicine (Baltimore). 2021;100(21):e25645.
Pongpirul WA, Wiboonchutikul S, Charoenpong L, Panitantum N, Vachiraphan A, Uttayamakul S, et al. Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): a retrospective observational analysis of 193 confirmed cases in Thailand. PLoS Negl Trop Dis. 2020;14(10):1–17.
Song YS, Hao YB, Liu WW, Zhang SS, Wang P, Fan TL. Clinical features of 17 patients with 2019-nCoV. Eur Rev Med Pharmacol Sci. 2020;24(20):10896–901.
Sun L, Shen L, Fan J, Gu F, Hu M, An Y, et al. Clinical features of patients with Coronavirus Disease 2019 from a designated hospital in Beijing, China. J Med Virol. 2020;92(10):2055–66.
Tan WYT, Wong LY, Leo YS, Toh MPHS. Does incubation period of COVID-19 vary with age? A study of epidemiologically linked cases in Singapore. Epidemiol Infect. 2020;148:e197.
Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multicentre case series. QJM. 2020;113(7):474–81.
Chen G, Wu MZ, Qin CJ, Wu BB, Luo WR, Liu L, et al. Epidemiological analysis of 18 patients with COVID-19. Eur Rev Med Pharmacol Sci. 2020;24(23):12522–6.
Yi B, Fen G, Cao D, Cai Y, Qian L, Li W, et al. Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China. Int J Infect Dis. 2021;105:113–9.
Liu H, Gao J, Wang Y, Jie J, Luo J, Xu Y, et al. Epidemiological and clinical characteristics of 2019 Novel Coronavirus Disease (COVID-19) in Jilin, China: a descriptive study. Medicine (Baltimore). 2020;99(47):e23407.
Liao J, Fan S, Chen J, Wu J, Xu S, Guo Y, et al. Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults. Innovation (Camb). 2020;1(1):100001.
Chen W, Hu C, Huang L, Cai M, Zhang Y, Wei H, et al. Epidemiological and clinical characteristics of COVID-19 patients in Nanjing. Research Square. 2020.
Gao Y, Ma X, Bi J, Chu J, Liu B, Chi C, et al. Epidemiological and clinical differences of Coronavirus Disease 2019 patients with distinct viral exposure history. Virulence. 2020;11(1):1015–23.
Liu P, Niu R, Chen J, Tang Y, Tang W, Xu L, et al. Epidemiological and clinical features in patients with Coronavirus Disease 2019 outside of Wuhan, China: special focus in asymptomatic patients. PLoS Negl Trop Dis. 2021;15(3):e0009248.
Deng L, Li Z, Liu Y, Li X, Jia N, Cui W, et al. Epidemiological and clinical findings of discharge patients infected with the 2019 novel coronavirus (SARS-COV-2) in Changchun, Northeast China: a retrospective cohort study. Acta Medica Mediterr. 2021;37(2):1147–53.
Alhamlan FS, Almaghrabi RS, Devol EB, Alotaibi AB, Alageel SM, Obeid DA, et al. Epidemiology and clinical characteristics of people with confirmed SARS-CoV-2 infection during the early COVID-19 pandemic in Saudi Arabia. Medicines (Basel). 2022;9(5):32.
pubmed: 35622071
Pung R, Chiew CJ, Young BE, Chin S, Chen MIC, Clapham HE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020;395(10229):1039–46.
Ejima K, Kim KS, Ludema C, Bento AI, Iwanami S, Fujita Y, et al. Estimation of the incubation period of COVID-19 using viral load data. Epidemics. 2021;35:100454.
Shen Q, Guo W, Guo T, Li J, He W, Ni S, et al. Novel coronavirus infection in children outside of Wuhan, China. Pediatr Pulmonol. 2020;55(6):1424–9.
Yang N, Shen Y, Shi C, Ma AHY, Zhang X, Jian X, et al. In-flight transmission cluster of COVID-19: a retrospective case series. Infect Dis (Lond). 2020;52(12):891–901.
Ai J-W, Chen J-W, Wang Y, Liu X-Y, Fan W-F, Qu G-J, et al. The cross-sectional study of hospitalized Coronavirus Disease 2019 patients in Xiangyang, Hubei province. medRxiv. 2020.
Qiu C, Deng Z, Xiao Q, Shu Y, Deng Y, Wang H, et al. Transmission and clinical characteristics of Coronavirus Disease 2019 in 104 outside-Wuhan patients, China. J Med Virol. 2020;92(10):2027–35.
Varghese B, Shajahan S, Anilkumar H, Haridasan RK, Rahul A, Thazhathedath H, et al. Symptomatology and epidemiologic characteristics of COVID 19 patients in Kerala, India. J Evol Med Dent Sci. 2020;9(46):3411–7.
Xie S, Zhang G, Yu H, Wang J, Wang S, Tang G, et al. The epidemiologic and clinical features of suspected and confirmed cases of imported 2019 Novel Coronavirus pneumonia in North Shanghai, China. Ann Transl Med. 2020;8(10):637–7.
Xu ZQ, Wu ZJ, Xu QB, Fang L, Cao XY, Chen WH, et al. The epidemiological characteristics of clusters of novel coronavirus pneumonia in Chenzhou, China. Acta Medica Mediterr. 2021;37(4):2187–9.
Chen J, Zhang ZZ, Chen YK, Long QX, Tian WG, Deng HJ, et al. The clinical and immunological features of pediatric COVID-19 patients in China. Genes Dis. 2020;7(4):535–41.
Breton V, Guiguet-Auclair C, Odoul J, Peterschmitt J, Ouchchane L, Gerbaud L. Population based survey of the COVID-19 outbreak in the Haut-Rhin department from January to April 2020. SSRN. 2020.
Galmiche S, Cortier T, Charmet T, Schaeffer L, Chény O, von Platen C, et al. SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study. Lancet Microbe. 2023;4(6):e409–e17.
Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291–300.
pubmed: 19393959
pmcid: 4327893
Vink MA, Bootsma MC, Wallinga J. Serial intervals of respiratory infectious diseases: a systematic review and analysis. Am J Epidemiol. 2014;180(9):865–75.
pubmed: 25294601
Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369(5):407–16.
pubmed: 23782161
pmcid: 4029105
Roll U, Yaari R, Katriel G, Barnea O, Stone L, Mendelson E, et al. Onset of a pandemic: characterizing the initial phase of the swine flu (H1N1) epidemic in Israel. BMC Infect Dis. 2011;11:92.
pubmed: 21492430
pmcid: 3098178
Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014;14(1):50–6.
pubmed: 24239323
Asiedu-Bekoe F, Adu DA, Offei A. Mass oseltamivir prophylaxis halts pandemic influenza A H1N1 2009 outbreak in a secondary school in Ashanti Region, Ghana. Ghana Med J. 2012;46(4):219–24.
pubmed: 23661840
pmcid: 3645174
Sun K, Wang W, Gao L, Wang Y, Luo K, Ren L, et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021;371(6526):eabe2424.
Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 2023;21(3):147–61.
pubmed: 36460930
Shuai H, Chan JF, Hu B, Chai Y, Yuen TT, Yin F, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022;603(7902):693–9.
Costa Clemens SA, Weckx L, Clemens R, Almeida Mendes AV, Ramos Souza A, Silveira MBV, et al. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Lancet. 2022;399(10324):521–9.
pubmed: 35074136
pmcid: 8782575
Buckner CM, Kardava L, El Merhebi O, Narpala SR, Serebryannyy L, Lin BC, et al. Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses. Cell. 2022;185(23):4333–46.e14.
WHO Coronavirus (COVID-19) Dashboard for Vaccination. https://covid19.who.int/?mapFilter=vaccinations . Accessed 20 Apr 2023.
Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A case series of children with 2019 Novel Coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020;71(6):1547–51.
pubmed: 32112072
Deeks JJ HJ, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane; 2022.